Journal of Pharmacology and Pharmacotherapeutics

RESEARCH PAPER
Year
: 2011  |  Volume : 2  |  Issue : 2  |  Page : 104--106

Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy


Deepika Singhal, Roopali Desai, Sejal Desai, Manisha Shastri, Deepak Saxena 
 Department of Ophthalmology, Surat Municipal Institute of Medical Education and Research, Surat, Indian Institute of Public Health, Gandhinagar, India

Correspondence Address:
Deepak Saxena
Indian Institute of Public Health, Gandhinagar - Gujarat
India

Objective: To study the effect of brimonidine on intraocular pressure (IOP) following capsulotomy among Indian subjects. Materials and Methods: The study was a nonrandomized trial with open label. Results: 80% of the subjects showed a decrease in IOP after instilling 0.2% brimonidine (1 hour pre capsulotomy). No such decrease was observed in control. After 1 and 4 h post capsulotomy a statistically significant decrease in IOP ranging between 1-10 mmHg was found in 73.3% of the treatment group. Conclusions: In the present study 0.2% brimonidine has been proven effective to counteract the increase in IOP following Nd-YAG laser capsulotomy in Indian setting.


How to cite this article:
Singhal D, Desai R, Desai S, Shastri M, Saxena D. Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy.J Pharmacol Pharmacother 2011;2:104-106


How to cite this URL:
Singhal D, Desai R, Desai S, Shastri M, Saxena D. Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy. J Pharmacol Pharmacother [serial online] 2011 [cited 2020 Aug 13 ];2:104-106
Available from: http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2011;volume=2;issue=2;spage=104;epage=106;aulast=Singhal;type=0